✦ LIBER ✦

Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure

✍ Scribed by Punniyakoti T. Veeraveedu; Kenichi Watanabe; Meilei Ma; Suresh S. Palaniyandi; Ken’ichi Yamaguchi; Kenji Suzuki; Makoto Kodama; Yoshifusa Aizawa

Book ID: 113488354
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 365 KB
Volume: 74
Category: Article
ISSN: 0006-2952
DOI: 10.1016/j.bcp.2007.07.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of Nonpeptide Vasopressin V2 Ant

Effects of Nonpeptide Vasopressin V2 Antagonist Tolvaptan (OPC-41061) in Rats with Heart Failure

✍ Punniyakoti Veeraveedu Thanikachalam; Kenichi Watanabe; Rajarajan Amirthalingam 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Tolvaptan, an Oral Vasopressin V2 Recept

Tolvaptan, an Oral Vasopressin V2 Receptor Antagonist for Heart Failure?

✍ Arthur Greenberg 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Effects of V2-receptor antagonist tolvap

Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure

✍ Punniyakoti T. Veeraveedu; Kenichi Watanabe; Meilei Ma; Suresh S. Palaniyandi; K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 349 KB

Effects of Tolvaptan, an Oral Vasopressi

Effects of Tolvaptan, an Oral Vasopressin V2 Receptor Antagonist, in Hyponatremia

✍ Nicolaos E. Madias 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Effects of the Vasopressin V2 Receptor A

Effects of the Vasopressin V2 Receptor Antagonist, Tolvaptan, on the Long-term Progression of Left Ventricular Dilatation in Patients with Heart Failure

✍ James E. Udelson 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Effects of tolvaptan, a vasopressin anta

Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial

✍ M Gheorghiade; W.A Gattis; C.M O'Connor 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 41 KB